SSP029 Sandrena®  0.5mg and 1mg gel sachets (RESTRICTION)

The Department of Health and Social Care (DHSC) has issued a Serious Shortage Protocol (SSP) for Sandrena®  0.5mg and 1mg gel sachets in response to a significant ongoing supply disruption.

This SSP will enable community pharmacists in England, Wales, Scotland and Northern Ireland to supply patients with a reduced quantity as per the document below.

It allows no more than three months’ supply to be supplied against prescriptions for Sandrena®  0.5mg and 1mg gel sachets (both branded and generically written).

In accordance with an SSP for a reduced quantity, if the patient normally pays for their prescriptions, no prescription charge is payable for the reduced quantity supply. This only applies to prescriptions that are for more than three months’ supply, and prescriptions for an amount less than or equivalent to three months’ supply should be dispensed as usual and if the patient pays for their prescriptions, the usual patient charges will still apply.

SSP029 for Sandrena®  0.5mg and 1mg gel sachets will be in operation from Friday 20th May 2022 until Friday 27th January 2023 (UPDATED EXPIRY DATE).

Please note that the SSP may be amended or revoked at any time, so contractors must ensure that the SSP is still valid before each supply.

Sandrena®  0.5mg and 1mg gel sachets SSP029

Serious Shortage Protocol SOP